In vivo 18F‑fluorodeoxyglucose‑positron emission tomography/computed tomography imaging of pancreatic tumors in a transgenic rat model carrying the human KRASG12V oncogene

Shibata,Koji; Fukamachi,Katsumi; Tsuji,Atsushi; Saga,Tsuneo; Futakuchi,Mitsuru; Nagino,Masato; Tsuda,Hiroyuki; Suzui,Masumi

doi:10.3892/ol.2015.3053

In vivo 18F‑fluorodeoxyglucose‑positron emission tomography/computed tomography imaging of pancreatic tumors in a transgenic rat model carrying the human KRASG12V oncogene

Authors:
- Koji Shibata
- Katsumi Fukamachi
- Atsushi Tsuji
- Tsuneo Saga
- Mitsuru Futakuchi
- Masato Nagino
- Hiroyuki Tsuda
- Masumi Suzui
View Affiliations

Affiliations: Department of Molecular Toxicology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Aichi 467‑8601, Japan, Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Chiba 263‑8555, Japan, Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466‑8550, Japan, Laboratory of Nanotoxicology Project, Nagoya University, Nagoya, Aichi 467‑8603, Japan
Published online on: March 18, 2015 https://doi.org/10.3892/ol.2015.3053
Pages: 2112-2118

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A novel KRAS‑mediated transgenic rat model has previously been demonstrated, in which animals develop multiple pancreatic ductal adenocarcinoma (PDAC) that is histologically similar to human PDAC within two weeks. Positron emission tomography (PET)/computed tomography (CT) is commonly used for the diagnosis and staging of PDAC in humans, and can be adopted for optimal use in animal experiments. The aim of the present study was to evaluate the carcinogenic process in a rat pancreatic carcinoma model using small‑animal multimodality imaging systems. The utility of fluorodeoxyglucose (FDG)‑PET/CT in detecting the location and size of PDAC during tumor development in the present transgenic rat model was assessed. A small animal multimodality PET/CT system and contrast‑enhanced CT (CECT) system were used for the imaging analysis of KRASG12V male transgenic rats (n=6), which developed pancreatic tumors following the administration of an injection of Cre recombinase (Cre)‑carrying adenovirus. Laparotomies performed at six weeks post‑treatment revealed that all three (100%) Cre‑expressing rats developed pancreatic tumors that were <2 mm in diameter, none of which were detected by 18F‑FDG PET/CT or CECT. At eight weeks post‑treatment, the pancreatic tumors were heterogeneously visualized by 18F‑FDG‑PET/CT and CECT in two of the three rats. Furthermore, the autopsies confirmed that all three rats had developed pancreatic tumors. These novel findings provide evidence that the FDG‑PET/CT imaging system is a valuable tool for the evaluation of the carcinogenic process, and one which may aid in treatment and preventive methods for pancreatic tumors in mammalian models. A limitation associated with the early detection of PDACs warrants further investigation.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
2	Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T and Nishimoto H: Japan Cancer Surveillance Research Group: Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 43:328–336. 2013. View Article : Google Scholar : PubMed/NCBI
3	Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP and Boffetta P: Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 51:3–13. 2012. View Article : Google Scholar : PubMed/NCBI
4	Cubilla AL and Fitzgerald PJ: Cancer of the exocrine pancreas: the pathologic aspects. CA Cancer J Clin. 35:2–18. 1985. View Article : Google Scholar : PubMed/NCBI
5	Morohoshi T, Held G and Klöppel G: Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology. 7:645–661. 1983. View Article : Google Scholar : PubMed/NCBI
6	Wolfgang CL, Herman JM, Laheru DA, et al: Recent progress in pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
7	Siegel R, Naishadham D and Jemal A: Cancer statistics. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
8	Fukamachi K, Tanaka H, Hagiwara Y, et al: An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas. Biochem Biophys Res Commun. 390:636–641. 2009. View Article : Google Scholar : PubMed/NCBI
9	Ueda S, Fukamachi K, Matsuoka Y, et al: Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis. 27:2497–2510. 2006. View Article : Google Scholar : PubMed/NCBI
10	Yabushita S, Fukamachi K, Tanaka H, et al: Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Carcinogenesis. 34:1251–1259. 2013. View Article : Google Scholar : PubMed/NCBI
11	Yabushita S, Fukamachi K, Kikuchi F, et al: Twenty-one proteins up-regulated in human H-ras oncogene transgenic rat pancreas cancers are up-regulated in human pancreas cancer. Pancreas. 42:1034–1039. 2013. View Article : Google Scholar : PubMed/NCBI
12	Yabushita S, Fukamachi K, Tanaka H, et al: Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Pancreas. 41:1013–1018. 2012. View Article : Google Scholar : PubMed/NCBI
13	Asagi A, Ohta K, Nasu J, et al: Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas. 42:11–19. 2013. View Article : Google Scholar : PubMed/NCBI
14	Tomimaru Y, Takeda Y, Tatsumi M, et al: Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep. 24:613–620. 2010.PubMed/NCBI
15	Lan BY, Kwee SA and Wong LL: Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 204:232–241. 2012. View Article : Google Scholar : PubMed/NCBI
16	Studwell AJ and Kotton DN: A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine. Mol Ther. 19:1933–1941. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kanegae Y, Lee G, Sato Y, et al: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816–3821. 1995. View Article : Google Scholar : PubMed/NCBI
18	Fendrich V, Schneider R, Maitra A, Jacobsen ID, Opfermann T and Bartsch DK: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. Neoplasia. 13:180–186. 2011. View Article : Google Scholar : PubMed/NCBI
19	van Kouwen MC, Laverman P, van Krieken JH, Oyen WJ, Jansen JB and Drenth JP: FDG-PET in the detection of early pancreatic cancer in a BOP hamster model. Nucl Med Biol. 32:445–450. 2005. View Article : Google Scholar : PubMed/NCBI
20	Russell WMS and Burch RL: The Principles of Humane Experimental Technique2nd. Methuen & Co; London: 1992
21	Kitahashi T, Mutoh M, Tsurusaki M, et al: Imaging study of pancreatic ductal adenocarcinomas in Syrian hamsters using X-ray micro-computed tomography (CT). Cancer Sci. 101:1761–1766. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kayed H, Meyer P, He Y, et al: Evaluation of the metabolic response to cyclopamine therapy in pancreatic cancer xenografts using a clinical PET-CT system. Transl Oncol. 5:335–343. 2012. View Article : Google Scholar : PubMed/NCBI
23	Sakai T, Tsushima T, Kimura D, Hatanaka R, Yamada Y and Fukuda I: A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma. Ann Thorac Cardiovasc Surg. 17:539–543. 2011. View Article : Google Scholar : PubMed/NCBI